NVONovo Nordisk A/S Stock Analysis

Exchange: NYSE | Sector: Healthcare | Industry: Drug Manufacturers - General

Current Price: $36.98 (+0.38% today)

Market Cap: $164.32B

P/E (TTM): 10.30

Forward P/E (FY1): 1.80

EPS Growth: 3.1%

Analyst Upside: 37.9%

Relative Strength (RS%): 62

-54.6% from 52-week high

Back to Scanner

NVO

NYSERS 62Score 39

Novo Nordisk A/S

HealthcareDrug Manufacturers - General$164.32B1 setup passing
$36.98
+0.4% ($0.14)
-54.6% from 52W High
P/E (TTM)
10.30
Fwd P/E
1.80
PEG
Analyst Upside
+37.9%
EPS Growth
3.1%
Gross Margin
81.0%
ROE
61.1%
D/E
0.67
Div Yield
5.0%
Avg Volume
14.7M

Price Chart

Key Levels

SMA 200
$53.29
SMA 50
$44.64
Price
$36.98
52W High
$81.45
Target
$51.00

Setup Radar

1/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst